Zurich Cantonal Bank’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Zurich Cantonal Bank’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-281	Closed	-$9.07K	–	2947
2025 Q3	$9.73K	Sell	281 -128	-31%	-$4.09K	﹤0.01%	2500
2025 Q2	$11.4K	Sell	409 -46	-10%	-$1.23K	﹤0.01%	2514
2025 Q1	$11.4K	Buy	+455	New	+$11.5K	﹤0.01%	2584
2023 Q1	–	Sell	-437	Closed	-$19.4K	–	2862
2022 Q4	$19.4K	Sell	437 -84	-16%	-$3.54K	﹤0.01%	2758
2022 Q3	$22K	Hold	521	–	–	﹤0.01%	2779
2022 Q2	$29K	Sell	521 -26	-5%	-$1.54K	﹤0.01%	2731
2022 Q1	$34K	Buy	+547	New	+$33.5K	﹤0.01%	2594

Other funds holding LKFT

Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

MAP

Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

DCM

DME Capital Management New York $3.19B AUM 23.22% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Zurich Cantonal Bank's LKFT Position: Q4 2025 in Review

Zurich Cantonal Bank sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q4 2025, closing a stake of 281 shares — an estimated $9.07K sold.

Zurich Cantonal Bank first reported a position in LKFT in Q1 2022 and held it in 7 quarters. The position peaked at $34K in Q1 2022. 90 funds tracked by Wall St. Rank hold LKFT as of Q4 2025.

Zurich Cantonal Bank reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q4 2025 after selling out during the quarter.
Zurich Cantonal Bank sold 281 Lakefront Biotherapeutics American Depositary Shares shares in Q4 2025, an estimated $9.07K.
Zurich Cantonal Bank first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and held it in 7 quarters.
Zurich Cantonal Bank's Lakefront Biotherapeutics American Depositary Shares position peaked at $34K in Q1 2022.
90 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q4 2025.

Based on Zurich Cantonal Bank's 13F filing for Q4 2025, filed 27 Jan 2026.